医薬品受託包装の市場規模・シェア・成長分析 (種類別、包装材別、地域別)：産業予測 (2024～2031年)

世界の医薬品受託包装の市場規模は、2022年に56億5,000万米ドルと評価され、2023年の61億1,000万米ドルから2031年には109億1,000万米ドルに拡大し、予測期間 (2024～2031年) に7.51%のCAGRで成長する見通しです。

高品質化学包装市場は、新興市場における受託包装業者向け需要の高まりと、製薬部門におけるアウトソーシングの動向に後押しされ、大きな成長が見込まれています。製薬企業は、製造コストを下げる戦略として受託包装サービスを利用するようになってきており、特に、多くの小規模製薬企業が直面する課題 (社内の包装材・専門知識・財源への制約など) に直面しています。こうした小規模製薬企業は、こうした制約を効果的に乗り切るために、受託包装機関 (CPO) や受託製造機関 (CMO) と有益なパートナーシップを結んでいます。包装ソリューションのアウトソーシングは、先進技術へのアクセスを提供するだけでなく、企業が中核事業分野に集中し、包装プロセスを合理化し、サービス効率を高めることを可能にするからです。その結果、CPOや受託開発・製造機関 (CDMO) は、競争情勢の中で業務を最適化し、高品質の包装ソリューションを確保しようとする製薬企業にとって、ますます好ましい選択肢となりつつあります。このダイナミックな進化は、市場における製薬メーカーの能力と競争力を高める上で、アウトソーシングが果たす重要な役割を浮き彫りにしています。

目次

イントロダクション

• 分析目的
• 定義
• 市場範囲

分析手法

• 情報調達
• 二次データソースと一次データソース
• 市場規模予測
• 市場の想定と制限

エグゼクティブサマリー

• 市場の概要と見通し
• 需給動向の分析
• セグメント別の機会分析

市場力学と見通し

• 市場動向
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• ポーターの分析

主な市場の考察

• 主な成功要因
• 競合の程度
• 主な投資機会
• 市場のエコシステム
• 規制情勢
• バリューチェーン分析
• PESTEL分析
• 原材料の分析

医薬品受託包装市場：種類別

• 市場概要
• 一次包装
  • ボトル
  • バイアル
  • アンプル
  • ブリスターパック
  • その他
• 二次包装
• 三次包装

医薬品受託包装市場：包装材別

• 市場概要
• プラスチック・ポリマー
• 紙・板紙
• ガラス
• アルミホイル
• その他

医薬品受託包装市場：地域別

• 市場概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ
• 中東・アフリカ (MEA)
  • 湾岸協力会議 (GCC) 諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング (2023年)
• 主な市場企業が採用した戦略
• 市場における最近の活動
• 主要企業の市場シェア (2023年)

主要企業プロファイル

• Amcor plc
• Newell Brands
• Nipro Corporation
• Daito Pharmaceutical Co., Ltd.
• Pfizer
• West Pharmaceutical Services, Inc.
• Smurfit Westrock
• Thermo Fisher Scientific Inc. (Patheon)
• Novo Holdings (Catalent, Inc.)
• Simtra BioPharma Solutions
• Kohlberg & Company LLC (PCI Pharma Services)
• Vetter Pharma International GmbH
• The McClay Foundation (Almac Group)
• CordenPharma International
• Aphena Pharma Solutions
• Ecobliss Packaging Group
• Recipharm AB
• Ropack Inc.
• Korber AG

Global Pharmaceutical Contract Packaging Market size was valued at USD 5.65 billion in 2022 and is poised to grow from USD 6.11 billion in 2023 to USD 10.91 billion by 2031, growing at a CAGR of 7.51% during the forecast period (2024-2031).

The market for high-quality chemical packaging is poised for significant growth, driven by rising demand from contract packers in emerging markets and a trend towards outsourcing within the pharmaceutical sector. Pharmaceutical companies are increasingly turning to contract packaging services as a strategy to lower manufacturing costs, particularly in the face of challenges such as limited in-house packaging materials, expertise, and financial resources that many small players encounter. These small pharmaceutical firms are forming beneficial partnerships with contract packaging organizations (CPOs) and contract manufacturing organizations (CMOs) to effectively navigate these constraints. The global expansion of the pharmaceutical industry further supports this trend, as outsourcing packaging solutions not only provides access to advanced technologies but also allows companies to focus on core business areas, streamline packaging processes, and enhance service efficiency. Consequently, CPOs and contract development and manufacturing organizations (CDMOs) are increasingly becoming the preferred choice for pharmaceutical companies seeking to optimize their operations and ensure high-quality packaging solutions amid a competitive landscape. This evolving dynamic underscores the vital role that outsourcing plays in elevating the capabilities and competitiveness of pharmaceutical manufacturers in the marketplace.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Contract Packaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmaceutical Contract Packaging Market Segmental Analysis

Global Pharmaceutical Contract Packaging Market is segmented by Type, Material, and region. Based on Type , the market is segmented into Primary Packaging (Bottles, Vials, Ampoules, Blister Packs, Others), Secondary Packaging, Tertiary Packaging. Based on Material, the market is segmented into Plastics & Polymers, Paper & Paperboard, Glass, Aluminum Foil, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pharmaceutical Contract Packaging Market

The Global Pharmaceutical Contract Packaging market is significantly driven by the increasing trend of outsourcing among pharmaceutical companies. As these organizations confront complex packaging requirements, stringent regulatory standards, and cost-performance pressures, they increasingly turn to specialized contract packaging providers. This strategic shift allows pharmaceutical firms to focus on core activities such as drug development and marketing, while benefiting from the expertise of contract packaging companies that can deliver innovative, compliant, and efficient packaging solutions. Consequently, this outsourcing trend not only enhances operational efficiency but also fosters better resource allocation, making it a pivotal factor in the growth of the contract packaging market.

Restraints in the Global Pharmaceutical Contract Packaging Market

The Global Pharmaceutical Contract Packaging market faces significant restraints due to the complexities of regulatory compliance that vary across different countries. Each region imposes distinct packaging and labeling guidelines, as well as stringent requirements for indestructible seals and durability warranties. The financial burden associated with meeting these diverse standards can be substantial, particularly for small- and medium-sized contract packaging firms that may lack the necessary resources. Moreover, the potential repercussions of non-compliance, such as product recalls or legal liabilities, further deter these companies from actively participating in the market, ultimately hindering overall market growth and innovation.

Market Trends of the Global Pharmaceutical Contract Packaging Market

The Global Pharmaceutical Contract Packaging market is witnessing a significant trend towards adopting sustainable packaging solutions, driven by heightened regulatory scrutiny and consumer demand for environmentally-friendly practices. Companies are increasingly prioritizing eco-conscious alternatives by integrating biodegradable plastics, recyclable materials, and minimizing bulky packaging. This shift is forcing packaging contract providers to invest in research and development initiatives aimed at creating innovative packaging products that align with stringent regulatory standards while also addressing sustainability goals. As governments enforce stricter environmental regulations and consumers champion greener initiatives, the emphasis on sustainable packaging is poised to grow, reshaping strategies within the pharmaceutical industry.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Regulatory Landscape
• Value Chain Analysis
• PESTEL Analysis
• Raw Material Analysis

Pharmaceutical Contract Packaging Market, By Type

• Market Overview
• Primary Packaging
  • Bottles
  • Vials
  • Ampoules
  • Blister Packs
  • Others
• Secondary Packaging
• Tertiary Packaging

Pharmaceutical Contract Packaging Market, By Material

• Market Overview
• Plastics & Polymers
• Paper & Paperboard
• Glass
• Aluminum Foil
• Others

Pharmaceutical Contract Packaging Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Amcor plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Newell Brands
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Daito Pharmaceutical Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• West Pharmaceutical Services, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smurfit Westrock
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. ( Patheon)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Holdings (Catalent, Inc.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Simtra BioPharma Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kohlberg & Company LLC (PCI Pharma Services)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetter Pharma International GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The McClay Foundation (Almac Group)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CordenPharma International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aphena Pharma Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ecobliss Packaging Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Recipharm AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ropack Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Korber AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments